DULUTH, Ga.–(BUSINESS WIRE)–National Vision, Inc., the nation’s second largest optical retailer providing quality, affordable eye care and eyewear, named the winners of its seventh annual scholarship program today, awarding three optometry students t…
Author: Business Wire
Aldeyra Therapeutics Announces Completion of Enrollment in Phase 3 TRANQUILITY-2 Trial in Patients with Dry Eye Disease
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company discovering and developing innovative therapies for the treatment of immune-mediated diseases, today announced completion of enrollment in t…
Stoke Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
BEDFORD, Mass.–(BUSINESS WIRE)–Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today announced that manageme…
Worldwide Phoropters Industry to 2027 – Specialty Clinics Hold a Significant Share in the Market – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Phoropters Market – Growth, Trends, COVID-19 Impact, and Forecasts (2022 – 2027)” report has been added to ResearchAndMarkets.com’s offering. The phoropters market studied is anticipated to witness a CAGR of nearly 4.1%, d…
Global Ocular Surgery Market to 2028 – Size, Share, Outlook, and Opportunity Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ocular Surgery Market, by Procedure Type, by Device Type, by End User, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028” report has been added to ResearchAndMarkets.com’s offering. Ocular surgery…
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)—- $KALV–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista’s board of directors granted one newly-hired employee inducement options to pur…
Global Optical Imaging Systems Market Size, Share & Trends Analysis Report Analysis 2022-2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optical Imaging Systems Market Size, Share & Trends Analysis Report Analysis by Technology, by Product, by Application, by End Use, by Therapeutic Area, by Region, and Segment Forecasts, 2022-2030” report has been adde…
OcuTerra Appoints Majid Anderesi, MD, as Vice President of Clinical and Medical Affairs
BOSTON–(BUSINESS WIRE)–OcuTerra Therapeutics, Inc. (“OcuTerra”), a clinical stage ophthalmology company developing innovative drugs to treat ophthalmic diseases for which the current standard of care of “watch-and-wait” does not prevent or control th…
NovaBay Pharmaceuticals Introduces Hydrating Cleansing Oil to its DERMAdoctor Calm Cool + Corrected Product Line
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a pharmaceutical company developing and commercializing high-quality, scientifically formulated eyecare and skincare products, announces the launch of Hydrating C…
ValenzaBio Announces FDA Clearance of Investigational New Drug Application for VB421, an Anti-IGF-1R Monoclonal Antibody for the Treatment of Thyroid Eye Disease
BETHESDA, Md.–(BUSINESS WIRE)–ValenzaBio, Inc., a biopharmaceutical company developing monoclonal antibody (mAb) therapeutics for autoimmune and inflammatory indications, today announced that its investigational new drug (IND) application for its lea…
Harrow Health Announces Appointments to Its Board of Directors
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow Health, Inc. (Nasdaq: HROW), an ophthalmic-focused healthcare company, today announced the appointments of Perry J. Sternberg and Marty Makary, M.D., M.P.H. to the Company’s Board of Directors, effect…
IngenioSpec’s Smart Eyewear Early Adopter Discount Program
SAN JOSE, Calif.–(BUSINESS WIRE)–IngenioSpec continues to license its smart eyewear patented technologies to large and small companies to bring its technologies to market.
Heru Featured in Scientific Program with Hands-On Demonstrations at the 2022 Vision Expo East Annual Meeting
MIAMI–(BUSINESS WIRE)–Vision diagnostics leader, Heru Inc., announced today that the company will be featuring two new testing modalities on its platform—Fast Pattern Suprathreshold Visual Field and the Farnsworth D-15 extended color vision exam—at V…
Mojo Vision Reaches Significant Development Milestone for Smart Contact Lens
SARATOGA, Calif.–(BUSINESS WIRE)–Mojo Vision, the Invisible Computing Company, today announced its most advanced prototype of Mojo Lens, the world’s first true smart contact lens, including an array of new, industry-first features. The Mojo Lens prot…
NovaBay Pharmaceuticals Reports 2021 Fourth Quarter and Full Year Financial Results
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) reports financial results for the three and 12 months ended December 31, 2021 and provides a business update. Financial results include the operations of the acqui…
ABIONYX Pharma annonce que la Food and Drug Administration (FDA) a accordé la désignation de médicament orphelin (ODD) au CER-001 pour le traitement du déficit en LCAT, dans la dysfonction rénale et/ou la maladie ophtalmologique
TOULOUSE, France & LAKELAND, Mich.–(BUSINESS WIRE)–Regulatory News: ABIONYX Pharma, (FR0012616852 – ABNX – éligible PEA PME) (Paris:ABNX), société biotech de nouvelle génération dédiée à la découverte et au développement de thérapies innovantes, anno…
ABIONYX Pharma Receives FDA Orphan Drug Designation (ODD) for CER-001 for the Treatment of LCAT Deficiency Presenting as Kidney Dysfunction and/or Ophthalmologic Disease
TOULOUSE, France–(BUSINESS WIRE)–Regulatory News: ABIONYX Pharma (FR0012616852 – ABNX – PEA PME eligible) (Paris:ABNX), a new generation biotech company dedicated to the discovery and development of innovative therapies for patients, today announced …
Aldeyra Therapeutics to Announce Top-Line Data for Systemic RASP Modulator ADX-629 at 2022 Research & Development Day
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company discovering and developing innovative therapies for the treatment of immune-mediated diseases, today will announce at its 2022 Research &…
Glaucoma Surgery Devices – Global Market Analysis and Forecast Model 2022 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Glaucoma Surgery Devices (Ophthalmic Devices) – Global Market Analysis and Forecast Model” report has been added to ResearchAndMarkets.com’s offering. The model discusses in detail the impact of COVID-19 on Glaucoma Surger…
What Physicians Want: Address Burnout, Staffing Concerns, Says 2022 Apollo Intelligence Global Healthcare Report
WATERTOWN, Mass.–(BUSINESS WIRE)–High levels of physician burnout, short staffing issues overshadow other optimistic findings in the 2022 Apollo Intelligence Global Healthcare Report.